Peter Hebert insider trades: Eikon Therapeutics (EIKN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
and 2 more companies
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | EIKN | ↑ Buy | 138,888 | $18.00 | $2.5M | Indirect | Feb 6, 2026 (2d) |
| Aug 16, 2023 | MTTR | ↑ Buy | 50,000 | $2.50 | $125K | Direct | Aug 18, 2023 (2d) |
| Feb 24, 2022 | MTTR | ↑ Buy | 20,000 | $6.38 | $128K | Direct | Feb 28, 2022 (4d) |
| Oct 13, 2016 | MRAM | ↑ Buy | 137,420 | $8.00 | $1.1M | Indirect | Oct 17, 2016 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About Peter Hebert's insider trades
Peter Hebert is an insider at Eikon Therapeutics (EIKN). Since Oct 13, 2016, Peter has reported 4 open-market purchases worth $3.9M and no sales on SEC Form 4. In the last 12 months: 1 buy ($2.5M).
Their filings also include other transactions (8 filings), grants and awards (6 filings), conversions (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.